User profiles for ALAIN SARAUX

Alain Saraux

U1227
Verified email at chu-brest.fr
Cited by 27464

The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis

GJ Tobón, P Youinou, A Saraux - Autoimmunity reviews, 2010 - Elsevier
Rheumatoid arthritis (RA) is a chronic inflammatory joint disease characterized by a distinctive
pattern of bone and joint destruction. RA patients have an increased risk of death. The …

EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

…, T Mandl, A Tzioufas, S Carsons, A Saraux… - Annals of the …, 2011 - ard.bmj.com
Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's
syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain, …

Treatment of primary Sjögren syndrome with rituximab: a randomized trial

…, JJ Dubost, JO Pers, E Nowak, A Saraux - Annals of internal …, 2014 - acpjournals.org
Background: Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by
ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and …

BAFF overexpression is associated with autoantibody production in autoimmune diseases

…, V Devauchelle, S Jousse, A Saraux… - Annals of the New …, 2005 - Wiley Online Library
The B‐cell activity factor (BAFF) acts as a positive regulator of B‐cell function. To gain further
insight into the understanding of B‐cell hyperactivity in autoimmune diseases, the serum …

Prevalence of rheumatoid arthritis in France: 2001

F Guillemin, A Saraux, P Guggenbuhl… - Annals of the …, 2005 - ard.bmj.com
Background: Prevalence estimates of rheumatoid arthritis (RA) vary across Europe. Recent
estimates in southern European countries showed a lower prevalence than in northern …

Prevalence of spondyloarthropathies in France: 2001

A Saraux, F Guillemin, P Guggenbuhl… - Annals of the …, 2005 - ard.bmj.com
Objective: To estimate the prevalence of spondyloarthropathies (SpAs) in France in a
multiregional representative sample in the year 2001. Methods: A two stage random sample was …

Improvement of Sjögren's syndrome after two infusions of rituximab (anti‐CD20)

…, B Cochener, P Youinou, A Saraux - Arthritis care & …, 2007 - Wiley Online Library
Alain SarauxAlain SarauxSaraux had full access to all of the data in the study and
takes responsibility for the integrity of the data and the accuracy of the data analysis. …

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

…, V Goeb, C Larroche, JJ Dubost, S Rist, A Saraux… - Jama, 2014 - jamanetwork.com
Importance Primary Sjögren syndrome is a systemic autoimmune disease characterized by
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity …

R Seror, H Bootsma, A Saraux, SJ Bowman… - Annals of the …, 2016 - ard.bmj.com
Objectives To define disease activity levels, minimal clinically important improvement (MCII)
and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) …

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)

…, G Valesini, E Bartoloni, A Saraux… - Annals of the …, 2015 - ard.bmj.com
Objectives To validate the two recently developed disease activity indexes for assessment of
primary Sjögren's syndrome (SS): the European League Against Rheumatism (EULAR) SS …